Ladenburg Thalmann Starts Trillium Therapeutics (TRIL) at Buy
Tweet
Share
E-mailGet Alerts TRIL Hot Sheet
Price: $19.86 --0%
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 3
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 3
Join SI Premium – FREE
Ladenburg Thalmann initiated coverage on Trillium Therapeutics (NASDAQ: TRIL) with a Buy rating and a price target of $18.00.
For an analyst ratings summary and ratings history on Trillium Therapeutics click here. For more ratings news on Trillium Therapeutics click here.
Shares of Trillium Therapeutics closed at $9.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Starts Terawulf Inc. (WULF) at Outperform
- Kepler Cheuvreux Starts OHB SE (OHB:GR) at Buy
- Deutsche Bank Starts Rhythm Pharmaceuticals (RYTM) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
